Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
anti-CD19 CAR T cell therapy
Locations
1
Germany
Universitätsklinikum Erlangen
Erlangen, Bavaria, Germany
Start Date
July 17, 2023
Primary Completion Date
May 31, 2026
Completion Date
May 31, 2026
Last Updated
September 30, 2025
NCT07089121
NCT06329401
NCT06875960
NCT03844061
NCT06335979
NCT06647069
Lead Sponsor
Miltenyi Biomedicine GmbH
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions